✦ LIBER ✦

Anti-TNF therapy in Ankylosing Spondylitis (AS). Is it possible to suspend treatment?

✍ Scribed by Jordi Gratacos Masmitja; Mireia Moreno Martinez-Losa

Book ID: 119648590
Publisher: Elsevier Science
Year: 2010
Tongue: Spanish
Weight: 184 KB
Volume: 6
Category: Article
ISSN: 2173-5743
DOI: 10.1016/s2173-5743(10)70055-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-TNF therapy in the treatment of ank

Anti-TNF therapy in the treatment of ankylosing spondylitis: the Finnish experience

✍ Liisa Konttinen; Riitta Tuompo; Tea Uusitalo; Riitta Luosujärvi; Kari Laiho; Juk 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 294 KB

Clinical response to discontinuation of

Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

✍ Xenofon Baraliakos, Joachim Listing, Jan Brandt… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 211 KB

F208 ANTI-TNFα THERAPY AND CONTROL OF CH

F208 ANTI-TNFα THERAPY AND CONTROL OF CHRONIC PAIN IN ANKYLOSING SPONDYLITIS (AS) AND RHEUMATOID ARTHRITIS (RA)

✍ J. Morović Vergles 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 61 KB

Correction: Clinical response to discont

Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

✍ Xenofon Baraliakos, Joachim Listing, Jan Brandt… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 27 KB

A case of infliximab-induced lupus in a

A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?

✍ Santiago, Tânia; Santiago, Mariana Galante; Rovisco, João; Duarte, Cátia; Malcat 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 117 KB

A case of infliximab-induced lupus in a

A case of infliximab-induced lupus in a patient with ankylosing spondylitis: is it safe switch to another anti-TNF-α agent?

✍ Santiago, Tânia; Santiago, Mariana Galante; Rovisco, João; Duarte, Cátia; Malcat 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 117 KB

Anti-TNF-α therapies are the latest class of medications found to be associated with drug-induced lupus, a distinctive entity known as anti-TNF-α-induced lupus (ATIL) (Williams et al., Rheumatology (Oxford) 48:716-20, 2009; De Rycke et al., Lupus 14:931-7, 2005; De Bandt et al., Clin Rheumatol 22:56